You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG …

Article metrics

Article menu
XML
Immune cell therapies and immune cell engineering
Original research
Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice

 

Online download statistics by month:

Online download statistics by month: July 2021 to April 2023

AbstractFullPdf
Jul 2021603604275
Aug 2021260259104
Sep 202116216189
Oct 202112012057
Nov 202111411136
Dec 2021949672
Jan 2022777951
Feb 2022859276
Mar 202211111972
Apr 202213114666
May 2022818652
Jun 202211511850
Jul 202211412049
Aug 202212513243
Sep 202211812660
Oct 2022899353
Nov 202210110056
Dec 2022686836
Jan 202310610658
Feb 202313714059
Mar 2023889180
Apr 2023747446
Total297330411540